30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Neervannan Seshadri

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 69% 68% 82%
Transactions
13 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Neervannan Seshadri's trades of Tarsus Pharmaceuticals, Inc.'s stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-24 2026-03-20
PlS Planned sale
42,697 +9.1%
305.20
US$4,905,022 		42,697 +9.1% 305.20 US$4,905,022
2026-03-20 2026-03-20
PrS Proposed sale
29,879
394.76
US$1,665,394 		29,879 394.76 US$1,665,394
2026-03-19 2026-03-19
S Sale
33,266 +26.7%
433.63
US$3,240,298 		33,266 +26.7% 433.63 US$3,240,298
2026-03-19 2026-03-19
PrS Proposed sale
4,589
67.00
US$307,457 		4,589 67.00 US$307,457
2026-03-19 2026-03-18
S Sale
3,610 -3.8%
68.71
US$248,043 		3,610 -3.8% 68.71 US$248,043
2026-03-18 2026-03-18
PrS Proposed sale
3,610
68.71
US$248,042 		3,610 68.71 US$248,042
2026-03-19 2026-03-17
S Sale
3,125 -3.2%
69.42
US$216,938 		3,125 -3.2% 69.42 US$216,938
2026-03-17 2026-03-17
PrS Proposed sale
3,125
69.41
US$216,921 		3,125 69.41 US$216,921
2026-03-05 2026-03-04
PlS Planned sale
8,366 -10.6%
76.67
US$641,421 		8,366 -10.6% 76.67 US$641,421
2026-03-04 2026-03-04
PrS Proposed sale
8,366
76.67
US$641,421 		8,366 76.67 US$641,421
2025-03-20 2025-03-20
PrS Proposed sale
2,435
50.11
US$122,026 		2,435 50.11 US$122,026
2025-03-20 2025-03-20
S Sale
2,435 -3.0%
50.11
US$122,018 		2,435 -3.0% 50.11 US$122,018
2025-03-20 2025-03-19
S Sale
2,543 -3.0%
47.40
US$120,538 		2,543 -3.0% 47.40 US$120,538
2025-03-19 2025-03-19
PrS Proposed sale
2,543
47.40
US$120,536 		2,543 47.40 US$120,536
2025-03-20 2025-03-18
S Sale
2,605 -3.0%
46.29
US$120,585 		2,605 -3.0% 46.29 US$120,585
2025-03-18 2025-03-18
PrS Proposed sale
2,605
46.28
US$120,571 		2,605 46.28 US$120,571
2024-03-19 2024-03-18
S Sale
4,879 -7.0%
30.60
US$149,297 		4,879 -7.0% 30.60 US$149,297
2024-03-18 2024-03-18
PrS Proposed sale
4,879
30.60
US$149,285 		4,879 30.60 US$149,285
2023-03-23 2023-03-23
S Sale
390 -0.7%
12.15
US$4,738 		390 -0.7% 12.15 US$4,738
2023-03-23 2023-03-22
S Sale
379 -0.7%
12.64
US$4,791 		379 -0.7% 12.64 US$4,791
2023-03-23 2023-03-21
S Sale
372 -0.7%
12.89
US$4,795 		372 -0.7% 12.89 US$4,795
2023-03-21 2023-03-20
S Sale
380 -0.7%
12.61
US$4,792 		380 -0.7% 12.61 US$4,792
2023-03-21 2023-03-17
S Sale
360 -0.6%
13.28
US$4,781 		360 -0.6% 13.28 US$4,781
2023-03-17 2023-03-16
S Sale
357 -0.6%
13.43
US$4,795 		357 -0.6% 13.43 US$4,795
2023-03-16 2023-03-16
PrS Proposed sale
2,300
13.66
US$31,418 		2,300 13.66 US$31,418